Thymosin α1 for Managing Radiation Pneumonitis in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy of thymosin α1 in management of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 20;[EPub Ahead of Print], F Liu, B Qiu, Y Xi, Y Luo, Q Luo, Y Wu, N Chen, R Zhou, J Guo, Q Wu, M Xiong, H LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.